Orphenadrine Extended-Release Tablets and Pasireotide Injection
Determining the interaction of Orphenadrine Extended-Release Tablets and Pasireotide Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: orphenadrine
Brand name: Norflex, Banflex, Orphenate, Flexoject, Flexon, Mio-Rel, Myolin, Orfro, Norflex Injectable, Antiflex
Synonyms: Orphenadrine
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Pasireotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Orphenadrine Extended-Release Tablets-Pasireotide Subcutaneous
- Orphenadrine Extended-Release Tablets-Patanase
- Orphenadrine Extended-Release Tablets-Patiromer
- Orphenadrine Extended-Release Tablets-Patiromer Sorbitex Calcium
- Orphenadrine Extended-Release Tablets-Pavacot
- Orphenadrine Extended-Release Tablets-Paxil
- Pasireotide Injection-Orphenadrine Injection
- Pasireotide Injection-Orphenadrine w/A.C.
- Pasireotide Injection-Orphenadrine, aspirin, and caffeine
- Pasireotide Injection-Orphenate
- Pasireotide Injection-Orphengesic
- Pasireotide Injection-Orphengesic Forte